» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 676-700 of 1083 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: The effect of the Raltegravir and Raltegravir/interferon beta tin patients with COVID-19 Design: This study is one blinded clinical trial. The study population will be all patients infected with COVID-19 admitted to Pymanieh hospital of Jahrom. 60 eligible patients will be selected conveniently and
IRCTID: IRCT20200412047042N1
in Tehran. For this purpose, 60 patients with the new coronavirus (COVID-19) will be included in the (...) ; sensitivity to drugs and alcohol • No intubation • Evidence of new coronavirus (COVID-19) (clinical or (...) Intervention groups: Sixty patients with the new coronavirus (COVID-19) are being studied. Patients are then
IRCTID: IRCT20150725023332N4
Study aim: Evaluating the effect of barley-based product on controlling the symptoms of hospitalized patients with COVID-19 and the recovery process Design: Randomized parallel clinical trial with control group, phase 3, design of 60 patients, random allocation software was used for randomization
IRCTID: IRCT20180923041093N6
Study aim: Investigation of the effects of prone position on respiratory status, hemodynamic, hospital stay and transfer to intensive care unit in patients with Covid-19 Design: The clinical trial is (...) secondary outcomes are evaluated. Participants/Inclusion and exclusion criteria: All patients with COVID-19
IRCTID: IRCT20160126026217N4
Study aim: Determination of the effect of orchicotherapy on the clinical course of patients with suspected covid 19 Design: Clinical trial with control group, with parallel, randomized groups, on 70 (...) : Entry criteria: patients admitted to the infected areas suspected of having covid 19; age 10 to 70 years
IRCTID: IRCT20180608040007N2
Study aim: Evaluation of Convalescent Plasma Therapy for COVID-19 Patients Design: This study is a randomized clinical trial (RCT) of the prospective applied research type. Two groups of 20 patients with severe disease are included in the study as intervention and control groups. People under the age of 60
IRCTID: IRCT20200503047281N1
moderate Covid-19 severity inpatients in Imam Ali hospital will be allocated to intervention or standard (...) : Inclusion criteria: Lung CT scan or PCR are appropriate for Covid-19 disease Age 18 to 60 years The oxygen
IRCTID: IRCT20200504047298N2
Study aim: Preparation of two oral herbal remedies including decoction and capsule and evaluation of their efficacy in patients with COVID-19 via a randomized clinical trial. Design: Randomized (...) diagnosis and treatment of COVID-19 requiring hospitalization and drug treatment. Thirty-four patients
IRCTID: IRCT20180712040449N2
  1. Evaluating the efficacy of herbal capsule in COVID-19 patients in a clinical trial
  2. Investigating the effect of Medical Beer on the fever of patients with COVID-19
  3. Explanation of Havay-e-Vabaie based on Iranian medicine and relation of it with epidemies. Determining the effect of the Iranian Medicine Product based on Mentha longifolia (nasal spray) on clinical and para clinical conditions of patients with COVID-19: clinical trial
  4. Evaluation and comparison of the effectiveness of three herbal products containing Noscapine (Opiucough, Noscough and Noscatem) on clinical symptoms and para-clinical parameters in adults hospitalized with severe COVID-19
  5. Evaluating the therapeutic effect of a mixed herbal drink of Marshmallow and Licorice on COVID 19 patients, A double blind clinical trial
  6. Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19: A double blind randomized clinical trial
  7. Double blind clinical trial study on Evaluation of the effectiveness of Ipecac homeopathic remedy in control of Clinical manifestations of COVID-19
  8. Evaluating the therapeutic effect of Phyllanthus Emblica on COVID 19 patients, A double blind clinical trial
  9. Investigating the effect of hot foot-bath on controlling the symptoms of hospitalized patients with COVID-19 and accelerating the recovery process
  10. Evaluation of Trifluoperazine Effectiveness in Treatment Process, Survival rate and Cure rate of COVID-19 Patients
Study aim: Comparison of the effectiveness and safety of the addition of Sofosbuvir plus Velpatasvir to standard treatment regimens in patients with COVID-19 Design: This study is one blinded clinical trial. The study population will be all patients infected with COVID-19 admitted to Golestan
IRCTID: IRCT20130812014333N145
Study aim: To determine the efficacy of different methods of administeration of combination regiemn including dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19 Design (...) : age 18-70 years old; severe COVID 19 disease. Exclusion: need for intubation; contraindication of
IRCTID: IRCT20120225009124N4
respiratory infection of patients with COVID-19 Design: This is a clinical trial. In this study, there are (...) triple blind manner. Participants/Inclusion and exclusion criteria: Patients with COVID-19, written and informed satisfaction of patients Intervention groups: Patients with COVID-19 who have the criteria for
IRCTID: IRCT20180610040049N4
Study aim: Evaluating the therapeutic effect of Phyllanthus Emblica e on COVID 19 patients, a double blind clinical trial Design: Randomize double blind clinical trial, with control group, with a (...) chain reaction (PCR) test confirmed infection with COVID 19. 3. Lung involvement in imaging 4
IRCTID: IRCT20200404046937N2
Study aim: Comparison of interactive psycho-educational interventions via social networks with placebo on anxiety and self-efficacy of patients infected with COVID-19 and lived in home quarantine (...) criteria of this study are aging ≥ 18 years, having diagnosis of COVID-19, being able to use cell phone
IRCTID: IRCT20130616013690N7
  1. The effectiveness of cognitive-behavioral stress management using the remote care system (application) of Covid 19 patients on the severity and duration of symptoms of this disease, psychological symptoms, psychosocial adaptation, cognitive status and changes in the level of ferritin and CRP and Spo2 in the blood of Covid 19 patients.
  2. The effect of motion-based self-care education on quality of life and life expectancy of patients with COVID-19
  3. The effect of motion-based self-care education on self-care behavior of patients with COVID-19 in Isfahan in 2022
  4. The effect of virtual relaxation technique training (Jacobson and Benson) on anxiety in home quarantine patients with Covid -19
  5. Efficacy of the barley-based remedy in the treatment of suspected novel coronavirus (COVID-19) pneumonia
  6. The Effect of Patient Education Through Social Media on COVID-19-Related Fear, Anxiety, and Self-care in Diabetes Patients
  7. The effect of online group support on psychological distress and self-care behaviors of the elderly with type 2 diabetes during the COVID-19 pandemic: a parallel randomized clinical trial
  8. Investigating the impact of breathing exercise ( through virtual education )on the general health of patients infected with Covid-19 in shiraz . Randomized clinical trial
  9. The Effect of Educational Intervention Based on Self-Care Strategies on Self-Compassion and COVID-19 Prevention in Nurses of Corona Wards in Hospitals Related to Shahid Beheshti University of Medical Science in 1400
  10. Investigating the effect of educational messages on the prevention of respiratory infectious diseases, with emphasis on Covid-19 based on the developed parallel process model, on risk control responses in diabetic middle-aged people
infection of patients with COVID-19 Design: This is a clinical trial. In this study, there are two groups (...) triple blind manner. Participants/Inclusion and exclusion criteria: Patients with COVID-19, written and informed satisfaction of patients Intervention groups: Patients with COVID-19 who have the criteria for
IRCTID: IRCT20180610040049N3
  1. The effect of natural medicine product (MOCOZIFT®) on clinical manifestations and para clinical features in patients with COVID-19: a randomized clinical trial
  2. The comparison of effectiveness of Tanacetum parthenium (L) Sch. syrups on clinical and paraclinical features of inpatients infected with 2019 novel coronavirus COVID-19, Parallel randomized trial
  3. Comparison Effect of Matricaria chamomilla and Trachyspermum Copticum on Withdrawal Syndrome in Narcotics Anonymous
  4. Study of Prednisolone effects on treatment and clinical symptoms and laboratory signs of Iranian COVID-19 patients: a clinical trial study
  5. The effect of Heilichrysum pseudoplicatum-syrupe on clinical manifestations and Para clinical features in patients with COVID-19: A Randomized clinical trial.
  6. Evaluating efficacy of Kelofan syrup, a traditional Iranian medicine product on pulmonary & other clinical and laboratory manifestations of patients with or probable of covid-19
  7. Comparison of the effectiveness of a mixture of plant extracts and placebo on the severity of symptoms in patients with irritable bowel syndrom: A randomized double blind clinical trial
  8. The effect of Trachyspermum Ammi syrup on the prevention of ventilator-associated pneumonia in mechanically ventilated patients in the trauma intensive care units
  9. The effect of Echinacea syrup on outcome in lower respiratory infections in patients with covid-19
  10. Study of Tocilizumab effect on treatment and clinical symptoms and laboratory signs of Iranian COVID-19 patients: a ‎crinical trial study
Study aim: Evaluation of the effectiveness of vitamin A on the clinical symptoms of COVID-19 disease, including the duration of fever, cough and shortness of breath, and on laboratory factors such as CPR, white blood cells, and creatinine. Design: Clinical trial with control group, with parallel
IRCTID: IRCT20200314046774N1
and mental health for the care team working in medical centers for patients with COVID-19 Design: A (...) for patients with COVID-19 2- Age between 23 and maximum 65 years; 3- Lack of physical and mental
IRCTID: IRCT20200413047052N1
  1. The effectiveness of online mindfulness training based on stress reduction (MBSR) on mental health and quality of work life of nurses fighting on the frontlines against COVID-19
  2. Effect of conflict resolution skills on moral distress and quality of life in neonatal intensive care unit nurses
  3. The effect of health messages on the quality of working life, burnout and stress among nurses working in intensive care units
  4. Comparison of the effectiveness of time management and resilience training on work- family conflict and psychological distress of female nurses
  5. Comparison of the efficacy of three versus five sessions of grief counseling on general health, quality of life and intensity of grief in family members of the COVID-19 victims: A multi-center randomized controlled trial
  6. Investigating the effect of an educational intervention based on the preced model on the quality of life of pregnant women referring to the health centers of Arak city during the COVID-19 pandemic.
  7. Design, implementation and evaluation of mental health promotion program based on Lazarus and Folkman theory on stress management in working women with work-life conflict
  8. The effect of cognitive-behavioral crisis intervention package on improving COVID-19 fear symptoms, improving quality of life and improving mental health in patients with corona
  9. The effectiveness of post marriage education on communication, conflict resolution, sexual satisfaction and marital satisfaction scores in newlyweds and quality of educational course from their views
  10. The Effect of Supportive-Educational Intervention on Caregiving Burden and Quality of Life of Family Caregivers of Gastric Cancer Patients Under Home-Based Palliative Care
Study aim: Determining the effectiveness of the natural product Faramir containing Salvia officinalis extract as antiviral and anti-inflammatory treatment in COVID-19 patients Design: Two arm (...) criteria: Inclusion criteria: Covid-19 infection confirmed by positive PCR-viral load test Some or all of
IRCTID: IRCT20170315033086N7
Study aim: Determining the effect of breathing exercises training on arterial oxygen saturation and anxiety in COVID-19 patients Design: A clinical trial with the control group, randomized, 70 Covid-19 patients Settings and conduct: Kamkar-Arabnia hospital in Qom city After completing the written consent of
IRCTID: IRCT20160716028948N2
Study aim: Assessment of the effect of Pinen.Hydronoplacton.Ribonucleic acid(PHR) spray in pulmonary problems of the patients with Covid-19 Design: Randomization method is cluster (...) COVID-19 confirmed by PCR and Ground glass view on CT scan.arterial oxygen saturation of less than 93
IRCTID: IRCT20160131026298N2
Study aim: To determine the safety and immunogenicity of COVID-19 inactivated vaccine in a healthy population Design: Phase I, randomized, double-blind, parallel arms, placebo-control clinical trial on 56 (...) COVID-19, history of close contact with COVID-19 patient in the last 14 days, abnormal paraclinical
IRCTID: IRCT20201202049567N1
  1. A double-blind, randomized, placebo-controlled Phase I Clinical trial to evaluate the safety and immunogenicity of COVID-19 inactivated vaccine (Shifa-Pharmed) in a healthy population aged 51-75 years
  2. A double-blind, randomized, placebo-controlled Phase II/III Clinical trial to evaluate the safety and efficacy of COVID-19 inactivated vaccine (Shifa-Pharmed) in a population aged 18 to 75 years
  3. Comparison of the tolerability, safety, and immunogenicity of Shifa-Pharmed COVID-19 inactivated vaccine (CovIran) and Sinopharm vaccine in the healthy population aged 12 to 18 years: a double-blind, randomized, active-controlled, Phase I-II clinical trial.
  4. A randomized, double-blinded, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of three dose regimens of COVID-19 RBD protein recombinant vaccine (AmitisGen; 80µg and 120µg) in a healthy population
  5. A Clinical trial to evaluate the immunogenicity and safety of Omicron-Based CovIran Barkat vaccine as a third injection dose in vaccinated population over 18 years of age
  6. A double-blind, randomized, placebo-controlled Phase II clinical trial to evaluate the immunogenicity and safety of covid-19 recombinant RBD protein vaccine (80 microgram) of Plasma Darman Sarve Sepid Co. in healthy population.
  7. Phase 2 trial of safety and immunogenicity of 10 micro gram inactivated SARS-CoV-2 vaccine (FAKHRAVAC), two doses two weeks apart in adults aged 18-70 years: a randomized, double-blind, placebo-controlled, clinical trial
  8. Phase 1, safety, immunogenicity and dose finding for two strengths of 0.5 × 10^6 and 2.5 × 10^6 (TCID50) inactivated SARS-CoV-2 vaccine FAKHRAVAC (MIVAC) injected in two schedules of two doses, 2 and 3 weeks apart in healthy adults aged 18-55 years: a randomized, double blind, placebo controlled, clinical trial
  9. Safety and immunogenicity of SARS-CoV-2 inactivated vaccine (OSVID-19) in healthy volunteers aged 18 to 40 years: A clinical trial, phase 1, single arm
  10. Efficacy, safety, and immunogenicity of Soberana recombinant vaccine (product of Finlay Institute) based on RBD protein subunit of Sars-Cov-2 in a 2-dose regimen with and without a booster dose: a double-blind, randomized, placebo-controlled phase III clinical trial in the Iranian population of 18-80 years
Study aim: according to the limitation of using drugs in children with covid-19 and in the other (...) diagnosis of covid including positive PCR test and chest radiography coming to 17 sahrivar hospital in rasht (...) severe covid or patients who hospitalized in ICU Intervention groups: the first group receives 600mg of
IRCTID: IRCT20220516054879N1
  1. Effect of N-acetyl cysteine on expression of Oxidation-Reduction genes of (FKBP4 ,PRDX6,NRF1,NRF2,GPX3 and MTHFR) during implantation window in women with Recurrent Implantation Failure: A Randomized, Placebo-Controlled, patient and assessor blinded, Phase 2 Clinical Trial
  2. Comparison of vitamin D3 and N-acetylcysteine prescription in COVID19 patients and their effect on recovery process
  3. Study of therapeutic effect of melatonin in patients with COVID-19 : a double-blind randomized clinical trial
  4. Clinical trial Comparing The Impact Of Selenium, Vitamine C And N-Acetylcystein On Prevention Of Acute Kidney Injury Following Off-Pump coronary artery bypass graft(CABG)
  5. The effect of combination therapy with insulin and synbiotic on platelet indices in children with type 1 diabetes
  6. Comparison of the Effect of Turmeric Extract and Placebo Capsule on Alpha Tumor Necrosis Factor (TNF-α) Inflammatory Factor Interleukin-6 (IL-6) and Inflammatory Factor 1-Beta (IL-1β) in Patients with Covid-19
  7. Investigation of simultaneous administration of biotin, brewer’s yeast, and vitamin C supplements on the improvement of clinical symptoms in patients with COVID-19
  8. Evaluation of the effect of melatonin in the treatment of patients with COVID19 compared ‎with placebo.
  9. Evaluation of antioxidant effects of NAC and vitamin B6 in comparison with NAC and placebo, in chemical warfare victims Chronic pulmonary lesions
  10. Investigating the effect of slow release mucosal drug in mouth " MUCODENTOL" on disease Symptoms in COVID-19 patients.
valuable insights into the role of rosuvastatin in the management of COVID-19. Design: Two arm parallel (...) interventional study conducted on 100 patients hospitalized with COVID-19. In this study, patients were randomly (...) included patients who were not currently taking statin treatment and had a confirmed diagnosis of COVID-19
IRCTID: IRCT20230722058883N2
patients with Covid-19 Design: A randomized, three-sided, randomized controlled clinical trial on 129 (...) population is all patients with Covid-19 hospitalized in the general wards of Shahid Labbafinejad Hospital in (...) exclusion criteria: Admission: All patients with Covid - 19 approved by the doctor - Age 18-70 years - Level
IRCTID: IRCT20201128049520N1
diagnosis of COVID-19 in 2021 will be included in the study in a non-probable manner based on inclusion (...) Covid disease. The case group, in addition to routine treatment, undergoes centrifugation plasmapheresis (...) case-control groups in parallel Patients in the control group will receive routine treatments for Covid
IRCTID: IRCT20200414047076N2
be followed up for safety, immunogenicity, any adverse events, and COVID-19 incidence. Participants (...) / Main exclusion criteria: Confirmed, suspected, or asymptomatic COVID-19, History of SARS-CoV-2
IRCTID: IRCT20171122037571N4
  1. Comparison of the tolerability, safety, and immunogenicity of Shifa-Pharmed COVID-19 inactivated vaccine (CovIran) and Sinopharm vaccine in the healthy population aged 12 to 18 years: a double-blind, randomized, active-controlled, Phase I-II clinical trial.
  2. Phase I, Randomized, Double Blind, Placebo-controlled, Study of the Safety and Immunogenicity of mRNA-based COVID-19 Vaccine (COReNAPCIN) Produced by ReNAP Co. as Booster Dose in Healthy Population Aged 18-50 Years
  3. Comparison of immunogenicity and safety of Razi Cov Pars and Sinopharm booster doses in adults 18 years of age and older who have primarily vaccinated with Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial ‎
  4. Comparison of safety and immunogenicity of FAKHRAVAC and Sinopharm booster doses for adults 18 years of age and older, fully vaccinated by Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial
  5. Phase II, Safety and Immunogenicity of RAZI SARS-CoV-2 recombinant Spike protein vaccine (RAZI Cov Pars) in adults aged 18-70 years; a Randomised, double blind, parallel 2 arms clinical trial
  6. Safety evaluation of a quadrivalent recombinant influenza vaccine (serotypes of 2021/2022) manufactured by Nivad Pharmed Salamat, open label, single arm, in volunteers aged ≥ 18 years.
  7. A single armed, open label, clinical trial to evaluate the immunogenicity of SpikoGen® vaccine as booster dose (Spike protein, produced by CinnaGen company) in kidney transplant patients being fully vaccinated with Sinopharm vaccine
  8. A double-blind, randomized, placebo-controlled Phase II clinical trial to evaluate the immunogenicity and safety of covid-19 recombinant RBD protein vaccine (80 microgram) of Plasma Darman Sarve Sepid Co. in healthy population.
  9. Phase 2 trial of safety and immunogenicity of 10 micro gram inactivated SARS-CoV-2 vaccine (FAKHRAVAC), two doses two weeks apart in adults aged 18-70 years: a randomized, double-blind, placebo-controlled, clinical trial
  10. Immunogenicity and Safety of intranasal Razi Cov Pars as a booster dose in adult population; randomised, double blind, placebo controlled clinical trial
Loading...